Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation-Reference-Cited by-同舟云学术

Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation

Published:2016-10-17 Issue:12 Volume:29 Page:1317-1328
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Cruzado Josep M.¹,Pascual Julio²,Sánchez‐Fructuoso Ana³,Serón Daniel⁴,Díaz Joan M.⁵,Rengel Manuel⁶,Oppenheimer Federico⁷,Hernández Domingo⁸,Paravisini Alexandra⁹,Saval Núria⁹,Morales José M.¹⁰,

Affiliation:

1. Nephrology Department IDIBELL Hospital de Bellvitge Barcelona Spain

2. Nephrology Department Hospital del Mar Barcelona Spain

3. Nephrology Department Hospital Clínico San Carlos Madrid Spain

4. Nephrology Department Hospital Vall Hebron Barcelona Spain

5. Nephrology Department Fundació Puigvert Barcelona Spain

6. Nephrology Department Hospital Gregorio Marañón Madrid Spain

7. Kidney Transplant Department Hospital Clínic i Provincial de Barcelona Barcelona Spain

8. Nephrology Department Hospital Carlos Haya Málaga Spain

9. Medical Department Novartis Farmacéutica Barcelona Spain

10. Nephrology Department Hospital 12 Octubre Madrid Spain

Funder

Novartis Pharmaceuticals Corporation

Novartis

Astellas Pharma US

Sanofi

Amgen

Teva Pharmaceutical Industries

Federación Española de Enfermedades Raras

Publisher

Frontiers Media SA

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tri.12862

Reference36 articles.

1. System USRD.USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End‐Stage Renal Disease in the United States Bethesda National Institutes of Health.Natl Inst Diabetes Dig Kidney Dis 2007.

2. Electrocardiographic Left Ventricular Hypertrophy in Renal Transplant Recipients: Prognostic Value and Impact of Blood Pressure and Anemia

3. Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass

4. Left ventricular hypertrophy after renal transplantation: new approach to a deadly disorder

5. Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis;Transplantation Reviews;2024-07

2. Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis From TRANSFORM Study;Transplantation;2023-06-20

3. Natural compounds from botanical drugs targeting mTOR signaling pathway as promising therapeutics for atherosclerosis: A review;Frontiers in Pharmacology;2023-01-20

4. The impact of mTOR inhibitors in the regression of left ventricular hypertrophy in elderly kidney transplant recipients;Clinical Transplantation;2022-06-17

5. Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients;Transplantation Direct;2021-12-13